Alk-Abelló A/S
🇩🇰Denmark
Clinical Trials
153
Active:87
Completed:60
Trial Phases
5 Phases
Phase 1:51
Phase 2:21
Phase 3:27
+2 more phases
Drug Approvals
1
EMA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (105 trials with phase data)• Click on a phase to view related trials
Phase 1
51 (48.6%)Phase 3
27 (25.7%)Phase 2
21 (20.0%)Phase 4
5 (4.8%)Not Applicable
1 (1.0%)A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
Not Applicable
Not yet recruiting
- Conditions
- Allergic RhinoconjunctivitisAllergic Rhinitis
- Interventions
- Biological: HDM SLIT-tablet (12 SQ-HDM)Other: Placebo
- First Posted Date
- 2025-07-11
- Last Posted Date
- 2025-07-11
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 300
- Registration Number
- NCT07060885
- Locations
- 🇨🇳
Beijing Tongren Hospital, Capital Medical University, Beijing, China
Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic Rhinitis
- Conditions
- Allergic Rhinitis Due to House Dust MiteAllergic Asthma
- Interventions
- Drug: Standardised allergen extract from house dust mites
- First Posted Date
- 2023-11-30
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 100
- Registration Number
- NCT06151938
- Locations
- 🇨🇳
Ruijin-Hainan Hospital Shanghai Jiao Tong University School of Medicine (Hainan Boao Research Hospital), Qionghai, Hainan, China
The Effect of Allergic Rhinitis on Educational Outcomes
Recruiting
- Conditions
- Allergic Rhinitis
- First Posted Date
- 2023-05-31
- Last Posted Date
- 2023-05-31
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 150000
- Registration Number
- NCT05881577
- Locations
- 🇩🇰
ALK Abello, Hørsholm, Hovedstaden, Denmark
Observational Study of Allergic Rhinitis in Children
Recruiting
- Conditions
- Allergic Rhinitis
- First Posted Date
- 2022-12-19
- Last Posted Date
- 2022-12-19
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 1000
- Registration Number
- NCT05655858
- Locations
- 🇫🇷
Hôpital Necker-Enfants malades - AP-HP Service de Pneumologie et Allergologie Pédiatriques, Paris, France
Comparative Real World Effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets vs. Controls in Allergic Rhinitis and Asthma
- First Posted Date
- 2022-07-27
- Last Posted Date
- 2023-08-02
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 49844
- Registration Number
- NCT05476484
- Locations
- 🇩🇰
ALK, Hørsholm, Copenhagen, Denmark
- Prev
- 1
- 2
- 3
- 4
- 5
- 14
- Next
News
No news found